Aerobic Exercise Improves Type 2 Diabetes Mellitus-Related Cognitive Impairment by Inhibiting JAK2/STAT3 and Enhancing AMPK/SIRT1 Pathways in Mice
Copyright © 2022 Lili Lin et al..
Type 2 diabetes mellitus (T2DM) is a prevalent risk factor for cognitive impairment. Aerobic exercise can improve T2DM-related cognitive impairment; however, the possible mechanisms remain elusive. Thus, we assessed db/m mice and leptin receptor-deficient (db/db) mice that did or did not perform aerobic exercise (8 m/min, 60 min/day, and 5 days/week for 12 weeks). In this study, cognitive function was significantly impaired in the T2DM mice; aerobic exercise improved cognitive impairment through activating the AMPK/SIRT1 signalling pathway and inhibiting the JAK2/STAT3 signalling pathway in T2DM mice. However, after the application of RO8191 (JAK2 activator) or Compound C (AMPK inhibitor), the positive improvement of the exercise was evidently suppressed. Taken together, our data indicated that long-term aerobic exercise improves type 2 diabetes mellitus-related cognitive impairment by inhibiting JAK2/STAT3 and enhancing AMPK/SIRT1 pathways in mice.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2022 |
---|---|
Enthalten in: |
Disease markers - 2022(2022) vom: 12., Seite 6010504 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lin, Lili [VerfasserIn] |
---|
Links: |
---|
Themen: |
AMP-Activated Protein Kinases |
---|
Anmerkungen: |
Date Completed 18.05.2022 Date Revised 31.05.2022 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1155/2022/6010504 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM341015156 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM341015156 | ||
003 | DE-627 | ||
005 | 20231226010807.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1155/2022/6010504 |2 doi | |
028 | 5 | 2 | |a pubmed24n1136.xml |
035 | |a (DE-627)NLM341015156 | ||
035 | |a (NLM)35578689 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lin, Lili |e verfasserin |4 aut | |
245 | 1 | 0 | |a Aerobic Exercise Improves Type 2 Diabetes Mellitus-Related Cognitive Impairment by Inhibiting JAK2/STAT3 and Enhancing AMPK/SIRT1 Pathways in Mice |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.05.2022 | ||
500 | |a Date Revised 31.05.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Lili Lin et al. | ||
520 | |a Type 2 diabetes mellitus (T2DM) is a prevalent risk factor for cognitive impairment. Aerobic exercise can improve T2DM-related cognitive impairment; however, the possible mechanisms remain elusive. Thus, we assessed db/m mice and leptin receptor-deficient (db/db) mice that did or did not perform aerobic exercise (8 m/min, 60 min/day, and 5 days/week for 12 weeks). In this study, cognitive function was significantly impaired in the T2DM mice; aerobic exercise improved cognitive impairment through activating the AMPK/SIRT1 signalling pathway and inhibiting the JAK2/STAT3 signalling pathway in T2DM mice. However, after the application of RO8191 (JAK2 activator) or Compound C (AMPK inhibitor), the positive improvement of the exercise was evidently suppressed. Taken together, our data indicated that long-term aerobic exercise improves type 2 diabetes mellitus-related cognitive impairment by inhibiting JAK2/STAT3 and enhancing AMPK/SIRT1 pathways in mice | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a STAT3 Transcription Factor |2 NLM | |
650 | 7 | |a Stat3 protein, mouse |2 NLM | |
650 | 7 | |a Jak2 protein, mouse |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a Janus Kinase 2 |2 NLM | |
650 | 7 | |a EC 2.7.10.2 |2 NLM | |
650 | 7 | |a AMP-Activated Protein Kinases |2 NLM | |
650 | 7 | |a EC 2.7.11.31 |2 NLM | |
650 | 7 | |a Sirt1 protein, mouse |2 NLM | |
650 | 7 | |a EC 3.5.1.- |2 NLM | |
650 | 7 | |a Sirtuin 1 |2 NLM | |
650 | 7 | |a EC 3.5.1.- |2 NLM | |
700 | 1 | |a Wang, Yonghua |e verfasserin |4 aut | |
700 | 1 | |a Xu, Wenli |e verfasserin |4 aut | |
700 | 1 | |a Huang, Chaolu |e verfasserin |4 aut | |
700 | 1 | |a Hu, Jinrong |e verfasserin |4 aut | |
700 | 1 | |a Chen, Xixi |e verfasserin |4 aut | |
700 | 1 | |a Lv, Xinhuang |e verfasserin |4 aut | |
700 | 1 | |a Qin, Yuelin |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Xiaoyong |e verfasserin |4 aut | |
700 | 1 | |a Li, Haiyan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Disease markers |d 1990 |g 2022(2022) vom: 12., Seite 6010504 |w (DE-627)NLM01261307X |x 1875-8630 |7 nnns |
773 | 1 | 8 | |g volume:2022 |g year:2022 |g day:12 |g pages:6010504 |
856 | 4 | 0 | |u http://dx.doi.org/10.1155/2022/6010504 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2022 |j 2022 |b 12 |h 6010504 |